Literature DB >> 29069287

The concomitant apoptosis and EMT underlie the fundamental functions of TGF-β.

Jianguo Song1, Weiwei Shi1.   

Abstract

TGF-β's multipotent cellular effects and their relations are critical for TGF-β's pathophysiological functions. However, these effects may appear to be paradoxical in understanding TGF-β's functions. Apoptosis and epithelial-mesenchymal transition (EMT) are two fundamental events that are deeply linked to various physiological and disease-related processes. These two major cellular fates are subtly regulated and can be potently stimulated by TGF-β, which profoundly contribute to the biological roles of TGF-β. Moreover, these two events are also indirectly and directly correlated with TGF-β-mediated growth inhibition and are relevant to the current understanding of the roles of TGF-β in tumorigenesis and cancer progression. Although TGF-β-induced apoptosis and EMT can be singly independent cellular events, they can also be mutually exclusive but interrelated concomitant events in various cases. Thus, the modulation of apoptosis and EMT is essential for the seemingly paradoxical functions of TGF-β. However, the concomitant effect of TGF-β on apoptosis and EMT, the balance and regulated alterations of them are still been ignored or underestimated. This review focuses on the TGF-β-induced concomitant apoptosis and EMT. We aim to provide an insight in understanding their significance, balance, and modulation in TGF-β-mediated biological functions.
© The Author 2017. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  EMT; TGF-β; apoptosis; cancer progression; cell fate; tumorigenesis

Mesh:

Substances:

Year:  2018        PMID: 29069287     DOI: 10.1093/abbs/gmx117

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  10 in total

1.  Diosgenin inhibits the epithelial-mesenchymal transition initiation in osteosarcoma cells via the p38MAPK signaling pathway.

Authors:  Huaming Huang; Chao Nie; Xiaokang Qin; Jie Zhou; Lei Zhang
Journal:  Oncol Lett       Date:  2019-08-23       Impact factor: 2.967

2.  PNMA5 accelerated cellular proliferation, invasion and migration in colorectal cancer.

Authors:  Jie Lin; Xiaokang Zhang; Fan Meng; Fanlin Zeng; Weiyou Liu; Xin He
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

3.  An In Silico Analysis Reveals an EMT-Associated Gene Signature for Predicting Recurrence of Early-Stage Lung Adenocarcinoma.

Authors:  Yi Han; Fang Cheng Wong; Di Wang; Christoph Kahlert
Journal:  Cancer Inform       Date:  2022-05-23

4.  Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells.

Authors:  Markus Breunig; Jessica Merkle; Martin Wagner; Michael K Melzer; Thomas F E Barth; Thomas Engleitner; Johannes Krumm; Sandra Wiedenmann; Christian M Cohrs; Lukas Perkhofer; Gaurav Jain; Jana Krüger; Patrick C Hermann; Maximilian Schmid; Tamara Madácsy; Árpád Varga; Joscha Griger; Ninel Azoitei; Martin Müller; Oliver Wessely; Pamela G Robey; Sandra Heller; Zahra Dantes; Maximilian Reichert; Cagatay Günes; Christian Bolenz; Florian Kuhn; József Maléth; Stephan Speier; Stefan Liebau; Bence Sipos; Bernhard Kuster; Thomas Seufferlein; Roland Rad; Matthias Meier; Meike Hohwieler; Alexander Kleger
Journal:  Cell Stem Cell       Date:  2021-04-28       Impact factor: 25.269

5.  ATBF1 Participates in Dual Functions of TGF-β via Regulation of Gene Expression and Protein Translocalization.

Authors:  Mei Li; Anqi Zhang; Yanan Zheng; Jiajing Li; Jiyuan Zhao
Journal:  Biomolecules       Date:  2020-05-24

Review 6.  CXXC5: A novel regulator and coordinator of TGF-β, BMP and Wnt signaling.

Authors:  Xiangyang Xiong; Shuo Tu; Jianbin Wang; Shiwen Luo; Xiaohua Yan
Journal:  J Cell Mol Med       Date:  2018-11-27       Impact factor: 5.310

7.  Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis.

Authors:  Xiaoqiang Liu; Yanlong Wu; Zhengtao Zhou; Mingchuan Huang; Wen Deng; Yibing Wang; Xiaochen Zhou; Luyao Chen; Yu Li; Tao Zeng; Gongxian Wang; Bin Fu
Journal:  Int J Mol Med       Date:  2019-06-12       Impact factor: 4.101

8.  The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition.

Authors:  Kun Zhang; Mengxia Zhang; Qingbin Yao; Xiaohui Han; Yanmian Zhao; Lina Zheng; Guantong Li; Qi Liu; Yanan Chang; Peijun Zhang; Hongmei Cui; Zhemin Shi; Ting Chen; Zhi Yao; Tao Han; Wei Hong
Journal:  Theranostics       Date:  2019-10-12       Impact factor: 11.556

9.  Dual role of RACK1 in airway epithelial mesenchymal transition and apoptosis.

Authors:  Yue Pu; Yuan-Qi Liu; Yan Zhou; Yi-Fan Qi; Shi-Ping Liao; Shi-Kun Miao; Li-Ming Zhou; Li-Hong Wan
Journal:  J Cell Mol Med       Date:  2020-02-17       Impact factor: 5.310

Review 10.  The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target.

Authors:  Yun Yang; Wen-Long Ye; Ruo-Nan Zhang; Xiao-Shun He; Jing-Ru Wang; Yu-Xuan Liu; Yi Wang; Xue-Mei Yang; Yu-Juan Zhang; Wen-Juan Gan
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-22       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.